VISCOTEARS

This brand name is authorized in Australia, Finland, Spain, Turkey, UK.

Active ingredients

The drug VISCOTEARS contains one active pharmaceutical ingredient (API):

1
UNII 4Q93RCW27E - CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)
 

Polyacrylic acid is a hydrophilic, high molecular weight polymer of carboxyvinylic acid. The gel forms a transparent lubricating and moistening film on the surface of the eye. The preparation has a pH similar to that found in the normal tear film and is slightly hypotonic with respect to tears. Polyacrylic acid relieves the symptoms of irritation linked with dry eye syndromes and protects the cornea against drying out.

 
Read more about Carbomer

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 VISCOTEARS Eye gel MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
S01XA20 Artificial tears and other indifferent preparations S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals
Discover more medicines within S01XA20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 5503P, 5504Q, 8384G, 8578L, 9210R
ES Centro de información online de medicamentos de la AEMPS 60886
FI Lääkealan turvallisuus- ja kehittämiskeskus 002161, 445481, 464110, 503849, 521282
GB Medicines & Healthcare Products Regulatory Agency 139710, 147583, 163310, 31515, 50081
TR İlaç ve Tıbbi Cihaz Kurumu 8681738440010

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.